This dysregulation may occur as a result of recurrent chromosomal translocations, gene amplification, aberrant growth factor signaling or point mutations that stabilize Myc mRNA or protein and that tend to be affiliated with specific tumor types [2,3,4]. This evidence concerns the gene MYC and neoplasm.